Community

NHS introduces new holistic guidance for children with gender dysphoria

Monday, 28 April 2025 12:09AM UTC

The NHS is set to implement new guidance for children and young people with gender dysphoria, focusing on comprehensive assessments including neurodevelopmental screening and mental health, following a national review and changes in gender identity services.

The National Health Service (NHS) in the United Kingdom is set to implement new guidance regarding the care of children and young people presenting with gender dysphoria, with a focus on a more comprehensive and holistic approach. This shift marks a departure from the previous “medical model” employed by the now-closed Tavistock Gender Identity Development Service (GIDS) and will initially be adopted by established children’s gender clinics in London and Manchester later this year.

According to the upcoming guidance, all children referred to NHS gender clinics will undergo screening for neurodevelopmental conditions, including autism and attention deficit hyperactivity disorder (ADHD). The guidelines state: “Given the high prevalence of neurodiversity identified within this population, all those attending the NHS Children and Young People’s Gender Service should receive screening for neurodevelopmental conditions.”

This new approach emerges in the wake of several significant developments related to gender identity services and transgender rights in the UK. A recent ruling by the UK Supreme Court determined that the legal definition of “sex” refers to biological sex rather than acquired or self-identified gender, a decision regarded by some as a setback for transgender rights organisations.

Additionally, the guidance builds on findings from a review led by Baroness Hilary Cass, a paediatrician and former president of the Royal College of Paediatrics and Child Health. Baroness Cass published her final report on 10 April 2024 following an extensive national review of gender identity services for young people. Her report highlighted a disproportionately high prevalence of mental health and neurodevelopmental conditions among children and young people with gender dysphoria.

The recommendations of Baroness Cass's review have already prompted major policy changes, including a nationwide ban on prescribing puberty blockers to individuals under 18 experiencing gender dysphoria. The Tavistock Gender Identity Development Service was closed in March 2023 and replaced by new regional services adhering to the updated protocols.

Under the new guidance, healthcare professionals will carry out thorough assessments of children presenting with gender dysphoria. These evaluations will extend beyond neurodevelopmental screening to encompass mental health status, family relationships, and sexual development, including considerations of same-sex attraction.

The Daily Express is reporting that the guidance is expected to be published imminently for public consultation before full implementation. It is endorsed by political parties including the Conservatives and Labour, although it has faced criticism from LGBT+ Labour and LGBTQ+ advocacy groups within the UK and internationally.

This revised framework signifies the NHS’s commitment to providing a multidisciplinary approach in assessing and supporting children and young people with gender dysphoria, reflecting a broader range of factors affecting their wellbeing. The changes also mark a significant moment in the ongoing debate surrounding gender identity services and their provision in the United Kingdom.

Source: Noah Wire Services

More on this

https://www.nhs.uk/conditions/gender-dysphoria/ - This URL supports the description of gender dysphoria and its treatment approach in the NHS. It provides a foundational understanding of the condition being discussed in the article.
https://www.england.nhs.uk/long-read/children-and-young-peoples-gender-services-implementing-the-cass-review-recommendations/ - This URL corroborates the implementation of new gender services based on the Cass Review recommendations. It highlights changes in the approach to gender dysphoria care for children and young people.
https://www.gov.uk/government/news/ban-on-puberty-blockers-to-be-made-indefinite-on-experts-advice - This URL provides information on the ban of puberty blockers for under-18s, which is a policy change influenced by the Cass Review. It supports the claim of major policy changes in response to the review's findings.
https://www.england.nhs.uk/long-read/referral-pathway-for-children-and-young-peoples-gender-services-mental-health-services/ - This URL discusses the referral pathway for Children and Young People’s Gender Services, supporting the claim of new service structures and protocols for assessing gender dysphoria.
https://www.nhs.uk/conditions/gender-dysphoria/treatment/ - This URL explains the treatment options for gender dysphoria in the NHS, aligning with the article's discussion on comprehensive care approaches.
https://www.noahwire.com - This is the source article, which provides the foundational context and claims being supported by the other URLs. However, it does not offer external validation per se, but serves as the basis for the information discussed.
https://news.google.com/rss/articles/CBMic0FVX3lxTE9wekpGQnFaZUY5M2lqbGdIN29SY2VzYlU2YWlXTVV1ektnanRZZGF3a0ppdTF6VHF0VGVoUXhMZHN3V19xakxZdjl6SWFfNG80VExqNmRXaXg2NDJKQ28wZ3ZJR1ZoRWtlLTZHM1Ftc09PaFHSAXhBVV95cUxPb241dnhWU3V6VDBfTzNQTldWMEc5OHRpU1VlbDZaUGN4M1NwbjZzUUc2c1V1TG1QdENDc09HcGc2OVJOQXAyXzB2R1NkVWtmdHJHRjV3NXZfam5GeDJtRXVzV0NGSDU5TlhFQ0drVUVFRlE4Wk9iay0?oc=5&hl=en-US&gl=US&ceid=US:en - Please view link - unable to able to access data

Noah Fact Check Pro

The draft above was created using the information available at the time the story first emerged. We’ve since applied our fact-checking process to the final narrative, based on the criteria listed below. The results are intended to help you assess the credibility of the piece and highlight any areas that may warrant further investigation.

Freshness check

Score: 8

Notes: The narrative references recent events (Cass review finalised April 2024, Tavistock closure March 2023) and imminent guidance publication. No explicit indication of outdated information found. The Daily Express describes the guidance as 'imminent', suggesting current relevance.

Quotes check

Score: 9

Notes: Direct quote from NHS guidance matches phrasing typical of official health policy documents. No earlier identical phrasing found in open searches. Cass review dates align with published timelines.

Source reliability

Score: 5

Notes: Narrative originates from The Daily Express, which lacks the editorial rigour of specialist health publications. Policy details align with verifiable NHS developments, but outlet’s reputation requires cautious interpretation.

Plausibility check

Score: 8

Notes: Claims match known NHS timelines (Tavistock closure, Cass review implementation). Screening protocols for neurodiversity align with NHS England’s stated direction. Political endorsements mentioned are consistent with public party positions.

Overall assessment

Verdict (FAIL, OPEN, PASS): PASS

Confidence (LOW, MEDIUM, HIGH): HIGH

Summary: Claims align with verifiable NHS policy shifts and timelines. However, the sourcing via The Daily Express rather than primary NHS communications or specialist health outlets warrants caution. No factual inaccuracies detected regarding core policy changes.

NHS
gender dysphoria
children's health
neurodevelopmental screening
LGBTQ+ rights